Geneos Wealth Management’s iShares MSCI USA Value Factor ETF VLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.52M Sell
37,652
-569
-1% -$102K 0.15% 151
2026
Q1
$5.43M Buy
38,221
+38,133
+43,333% +$5.59M 0.13% 192
2025
Q4
$12K Hold
88
﹤0.01% 1906
2025
Q3
$11K Hold
88
﹤0.01% 1933
2025
Q2
$9.96K Hold
88
﹤0.01% 2329
2025
Q1
$9.38K Buy
88
+59
+203% +$6.43K ﹤0.01% 2281
2024
Q4
$3.06K Sell
29
-134
-82% -$14.7K ﹤0.01% 2480
2024
Q3
$17.8K Hold
163
﹤0.01% 1600
2024
Q2
$16.9K Hold
163
﹤0.01% 1392
2024
Q1
$17.7K Sell
163
-32
-16% -$3.27K ﹤0.01% 1394
2023
Q4
$19.7K Hold
195
﹤0.01% 1356
2023
Q3
$17.7K Hold
195
﹤0.01% 1419
2023
Q2
$18.3K Hold
195
﹤0.01% 1410
2023
Q1
$18.1K Buy
195
+120
+160% +$11.3K ﹤0.01% 1377
2022
Q4
$6.84K Hold
75
﹤0.01% 1635
2022
Q3
$6K Sell
75
-525
-88% -$48.7K ﹤0.01% 1665
2022
Q2
$54K Sell
600
-145
-19% -$14.3K ﹤0.01% 1254
2022
Q1
$77K Sell
745
-49
-6% -$5.24K ﹤0.01% 1193
2021
Q4
$86K Buy
794
+90
+13% +$9.47K ﹤0.01% 1232
2021
Q3
$71K Buy
704
+1
+0.1% +$104 ﹤0.01% 1323
2021
Q2
$74K Sell
703
-423
-38% -$44.6K ﹤0.01% 1300
2021
Q1
$117K Sell
1,126
-18
-2% -$1.74K ﹤0.01% 1226
2020
Q4
$83K Buy
1,144
+526
+85% +$42.8K ﹤0.01% 1214
2020
Q3
$44K Hold
618
﹤0.01% 1318
2020
Q2
$43K Sell
618
-43,720
-99% -$3.05M ﹤0.01% 1279
2020
Q1
$2.77M Sell
44,338
-10,095
-19% -$816K 0.19% 125
2019
Q4
$4.89M Buy
54,433
+47,799
+721% +$4.1M 0.26% 109
2019
Q3
$541K Buy
6,634
+341
+5% +$27.7K 0.03% 394
2019
Q2
$511K Buy
6,293
+5,319
+546% +$426K 0.03% 397
2019
Q1
$77K Sell
974
-52,454
-98% -$4.16M 0.01% 963
2018
Q4
$3.85M Sell
53,428
-6,424
-11% -$519K 0.28% 93
2018
Q3
$5.27M Buy
59,852
+25,884
+76% +$2.24M 0.35% 70
2018
Q2
$2.81M Buy
+33,968
New +$2.85M 0.22% 120

Other funds holding VLUE

Geneos Wealth Management's VLUE Position: Q2 2026 in Review

Geneos Wealth Management reduced its iShares MSCI USA Value Factor ETF (VLUE) stake by 1.5% in Q2 2026, selling an estimated $102K and leaving 37,652 shares worth $7.52M. The position accounts for 0.15% of the portfolio, ranked #151.

Geneos Wealth Management first reported a position in VLUE in Q2 2018 and has held it in 33 quarters since. 624 funds tracked by Wall St. Rank hold VLUE as of Q2 2026.

  • Geneos Wealth Management held 37,652 shares of iShares MSCI USA Value Factor ETF worth $7.52M as of Q2 2026.
  • Geneos Wealth Management sold 569 iShares MSCI USA Value Factor ETF shares in Q2 2026, an estimated $102K.
  • iShares MSCI USA Value Factor ETF made up 0.15% of Geneos Wealth Management's portfolio in Q2 2026, its #151 holding.
  • Geneos Wealth Management first reported a position in iShares MSCI USA Value Factor ETF in Q2 2018 and has held it in 33 quarters since.
  • 624 funds tracked by Wall St. Rank held iShares MSCI USA Value Factor ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.